Lopinavir and Ritonavir have High Affinity Toward the SARS-CoV-2 S-protein Receptor-binding Domain Sequenced in Brazil
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, resulting in the coronavirus disease 2019 (COVID-19) pandemic. Understanding the structural and functional interactions between the virus and host cells is...
Saved in:
Main Authors: | Aline Diogo Marinho, Helyson Lucas Bezerra Braz, João Alison de Moraes Silveira, Danilo Galvão Rocha, Roberta Jeane Bezerra Jorge, Geanne Matos de Andrade |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2025-01-01
|
Series: | BIO Integration |
Subjects: | |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/bioi-2024-0055 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HPTLC Method for Simultaneous Determination of Lopinavir and Ritonavir in Capsule Dosage Form
by: A. V. Sulebhavikar, et al.
Published: (2008-01-01) -
The Palatability of Lopinavir and Ritonavir Delivered by an Innovative Freeze-Dried Fast-Dissolving Tablet Formulation
by: David W. Pittman, et al.
Published: (2018-01-01) -
Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages
by: Patrícia de Almeida Machado, et al.
Published: (2025-01-01) -
Persistent hepatocyte secretory failure in lopinavir/ritonavir related to drug-induced liver injury: a case report
by: Yue Sun, et al.
Published: (2025-02-01) -
Functional Role of P-Glycoprotein and Binding Protein Effect on the Placental Transfer of Lopinavir/Ritonavir in the Ex Vivo Human Perfusion Model
by: Pierre-Francois Ceccaldi, et al.
Published: (2009-01-01)